Provenance du réseau au premier degré de Robert Scarborough
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 18 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Robert Scarborough via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Sanarus Medical, Inc.
 Sanarus Medical, Inc. Medical SpecialtiesHealth Technology Part of Sanarus Technologies LLC, Sanarus Medical, Inc. manufactures minimally invasive medical devices. The company is based in Pleasanton, CA. The company was founded in 1999 by Seth A. Stabinsky, Glenn Foy. The CEO is BJ Hardman. Sanarus Medical was acquired by Sanarus Technologies LLC on July 16, 2009. | Medical Specialties | Director/Board Member | |
| Alta BioPharma Management III LLC | Director/Board Member | ||
| IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| FIVE PRIME THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| ATV Associates VII LLC | Corporate Officer/Principal | ||
Microbia, Inc.
 Microbia, Inc. Pharmaceuticals: MajorHealth Technology Microbia, Inc. engages in the development of microbial manufacturing technologies for the production of chemicals from renewable raw materials. The company is headquartered in DE. | Pharmaceuticals: Major | Director/Board Member | |
| ASTRIA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Nimbus Therapeutics LLC
 Nimbus Therapeutics LLC BiotechnologyHealth Technology Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| MYOKARDIA, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| Stanford University | College/University | Undergraduate Degree Corporate Officer/Principal | |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | College/University | Doctorate Degree Undergraduate Degree | |
Agensys, Inc.
 Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Miscellaneous Commercial Services | Director/Board Member | |
BancBoston Ventures, Inc.
 BancBoston Ventures, Inc. Investment ManagersFinance BancBoston Ventures Inc. (BancBoston Ventures), a subsidiary of Bank of America, NA (Charlotte, North Carolina) is a venture capital firm founded in 1959. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Undergraduate Degree | |
| The University of Chicago | College/University | Undergraduate Degree Undergraduate Degree Corporate Officer/Principal | |
| The University of California, San Francisco | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal | |
| AVEO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
UCSF Benioff Children's Hospital Oakland
 UCSF Benioff Children's Hospital Oakland Hospital/Nursing ManagementHealth Services UCSF Benioff Children's Hospital Oakland provides healthcare services. It offers child life program, family outreach clinics, hand and microsurgery, parent infant programs, pastoral care, neurosurgery, injury prevention programs and respiratory care services. The company was founded by Bertha Wright in 1912 and is headquartered in Oakland, CA. | Hospital/Nursing Management | Director/Board Member | |
Excaliard Pharmaceuticals, Inc.
 Excaliard Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Excaliard Pharmaceuticals, Inc. manufactures, develops therapeutics for the treatment of scarring and fibrotic disorders. The company was founded by John Gordon Foulkes and Nicholas M. Dean in 2006 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member | |
| TREVENA, INC. | Pharmaceuticals: Major | Director/Board Member | |
CytomX Therapeutics Holdings LLC
 CytomX Therapeutics Holdings LLC Pharmaceuticals: MajorHealth Technology CytomX Therapeutics Holdings LLC engaged in the development of new generation targeted antibody therapeutics. The company was founded by Frederick W. Gluck on January 31, 2008 and is headquartered in Santa Barbara, CA. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| VERASTEM, INC. | Biotechnology | Director/Board Member | |
| KITE PHARMA INC | Biotechnology | Director/Board Member | |
| The University of North Carolina at Charlotte | College/University | Undergraduate Degree Masters Business Admin | |
| ALLAKOS INC. | Pharmaceuticals: Major | Director/Board Member | |
| Stanford Graduate School of Business | College/University | Masters Business Admin | |
| Simmons School of Management | College/University | Masters Business Admin | |
| CYTOMX THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Human Resources Officer | |
| CYTEIR THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Tizona Therapeutics, Inc.
 Tizona Therapeutics, Inc. BiotechnologyHealth Technology Tizona Therapeutics, Inc. is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases. Its products include anti-ccr4 antibody for the treatment of cancer, il-35 antagonists for the treatment of cancer, and il-35 agonists for the treatment of autoimmune diseases. The company was founded by Charles G. Drake, Vijay K. Kuchroo, Drew M. Pardoll, Dario Vignali, Wayne A. Marasco and Jedd D. Wolchok and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
Gemini Therapeutics Sub, Inc.
 Gemini Therapeutics Sub, Inc. BiotechnologyHealth Technology Gemini Therapeutics Sub, Inc. engages in the development of treatments for age-related macular degeneration (AMD) and linked ocular disorders. Its multimodal pipeline includes monoclonal antibodies, recombinant proteins and gene therapies. The company was founded by James McLaughlin, Johanna Seddon, Paul Barlow and Andrew Herbert in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Disarm Therapeutics, Inc.
 Disarm Therapeutics, Inc. BiotechnologyHealth Technology Disarm Therapeutics, Inc. engages in the development of therapeutics to treat patients with neurological diseases. It includes multiple sclerosis, amyotrophic lateral sclerosis, glaucoma, and peripheral neuropathies. The company was founded by Jason Rhodes, Jeffrey Milbrandt, Raul Krauss, Aaron DiAntonio, and Rajesh Devraj on October 21, 2016 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| EIDOS THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
Locanabio, Inc.
 Locanabio, Inc. Packaged SoftwareTechnology Services Locana, Inc. engages in the provision of ribonucleic acid targeting gene therapy. Its platform technology addresses a wide spectrum of human genetic diseases. It has advanced a powerful modular RNA targeting-effector approach to optimize and advance therapeutic candidates that is distinct from DNA-targeted approaches and nucleic acid-based RNA targeting. The company was founded by Gene Yeo and David Nelles in 2016 and is headquartered in San Diego, CA. | Packaged Software | Director/Board Member | |
| BRIDGEBIO PHARMA, INC. | Biotechnology | Founder Chief Tech/Sci/R&D Officer | |
| POPULATION HEALTH INVESTMENT CO., INC. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| GLOBAL BLOOD THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Founder Chief Tech/Sci/R&D Officer | |
LSV CAPITAL MANAGEMENT LLC
 LSV CAPITAL MANAGEMENT LLC Investment ManagersFinance LSV Capital Management LLC (Lightstone Ventures) is a venture capital firm founded in 2012. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor |
Statistiques
Internationale
| Etats-Unis | 48 |
| Canada | 2 |
| Îles Cayman | 2 |
| Irlande | 2 |
Sectorielle
| Health Technology | 32 |
| Consumer Services | 8 |
| Finance | 6 |
| Commercial Services | 3 |
| Distribution Services | 2 |
Opérationnelle
| Director/Board Member | 140 |
| Corporate Officer/Principal | 76 |
| Independent Dir/Board Member | 38 |
| Undergraduate Degree | 18 |
| Founder | 18 |
Relations les plus connectées
| Insiders | |
|---|---|
| Nicholas G. Galakatos | 38 |
| Jean George | 33 |
| Russell C. Hirsch | 31 |
| Jeff Bird | 30 |
| Charles Homcy | 29 |
| Farah Champsi | 19 |
| William Lis | 12 |
| Uma Sinha | 11 |
| Hsiao Lieu | 11 |
| Debanjan Ray | 10 |
| Sanjay Lakhotia | 10 |
| David R. Philips | 8 |
| Daniel D. Gretler | 8 |
| Pamela Conley | 8 |
| Stanley J. Hollenbach | 7 |
- Bourse
- Insiders
- Robert Scarborough
- Connexions Sociétés
